SCHEMBL7533261

SCHEMBL7533261

CC(C)(O)CCC1CC2C=CC1C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.41
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 3/20 0.35
USP2 O75604 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.33
LMNA P02545 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
HIF1A Q16665 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
PTGS2 P35354 1/20 0.31
HRH1 P35367 1/20 0.31
KCNH2 Q12809 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7539017 0.89 KDM4E (0.39) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL7533320 0.88 KDM4E (0.38) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL7532084 0.86 KDM4E (0.37) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL15800081 0.83 KDM4E (0.37) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL15803193 0.81 KDM4E (0.43) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL12357865 0.81 KDM4E (0.43) KDM4EALDH1A1TDP1USP2MEN1
SCHEMBL18408709 0.79 KDM4E (0.39) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL8402175 0.79 KDM4E (0.36) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL15779743 0.79 KDM4E (0.39) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL18713286 0.79 KDM4E (0.36) KDM4EALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469220-B2 MONOMERS FOR PHOTORESIST MATERIALS WITH HIGH TRANSPARENCY AND A GREAT AFFINITY FOR THE SUBSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-10-22 US disclosed
US-20020087033-A1 Novel tertiary alcohol compounds having an alicyclic structure SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020087033-A1 Novel tertiary alcohol compounds having an alicyclic structure ADH1A, ADH1C, ADH5 KDM4E 2665/4885ALDH1A1 5/4885TDP1 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.